Misyo (Methadone Hydrochloride)

Methadone Hydrochloride is employed in the management of pain and opioid dependence, acting on the central opioid pathways.

• Moderate to severe chronic pain: provides long‑acting analgesia for patients requiring sustained opioid control.
• Opioid dependence: used in maintenance therapy to reduce withdrawal symptoms and cravings, facilitating recovery.
• Palliative care: offers symptom relief for patients with advanced disease requiring opioid analgesia.
• Post‑operative pain: may be utilized when prolonged opioid analgesia is indicated.

• Methadone Hydrochloride acts primarily as a full agonist at the µ‑opioid receptor, producing analgesia and suppressing opioid withdrawal. It also antagonizes NMDA receptors and inhibits the reuptake of serotonin and norepinephrine, contributing to its analgesic and anti‑hyperalgesic properties. These combined actions result in both pain relief and stabilization of opioid dependence.

Methadone Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Constipation: reduced gastrointestinal motility.
• Nausea: upset stomach often occurring after dosing.
• Drowsiness: increased sedation, especially at higher doses.
• Sweating: excessive perspiration, particularly during dose adjustments.

Serious or Rare Side Effects

• Respiratory depression: marked reduction in breathing effort, potentially life‑threatening.
• QT interval prolongation: cardiac electrical disturbance that can lead to arrhythmia.
• Severe hypotension: sudden drop in blood pressure causing dizziness or fainting.

When prescribing or dispensing Methadone Hydrochloride, several safety considerations are essential.

• Dose titration: adjust gradually under medical supervision to minimize overdose risk.
• Respiratory monitoring: closely observe patients with compromised breathing function.
• Concomitant CNS depressants: avoid or use with caution due to additive sedation.
• Pregnancy: risk category unknown; weigh potential benefits against fetal risks.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Methadone Hydrochloride interacts with several drug classes; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Other opioids: combined use can cause severe respiratory depression.
• Benzodiazepines: additive central nervous system depression increases sedation risk.
• Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise methadone plasma concentrations.

Moderate Interactions (Monitor Closely)

• CYP2B6 inducers (e.g., rifampin): may lower methadone levels, reducing efficacy.
• QT‑prolonging agents (e.g., macrolide antibiotics): additive risk of cardiac arrhythmias.
• Alcohol: enhances sedative effects and may impair respiration.